What Deal Progression Means
Deal progression is defined as the validated forward movement of a sales opportunity through pipeline stages, driven by confirmed buyer milestones rather than seller activity. A deal progresses when the buyer takes a meaningful step: they agree to an evaluation, they present a business case internally, they engage procurement. Seller activity (sending a proposal, completing a demo) is necessary but does not constitute progression unless the buyer reciprocates. According to Gartner (2024), 44% of B2B deals that reach evaluation stall and never progress to the next stage, making progression analysis essential for pipeline health.Understanding where and why deals stop progressing reveals the biggest revenue opportunities in your pipeline.
How is deal progression tracked?
Deal progression is measured at three levels:
Stage advancement rate. What percentage of deals that enter a stage advance to the next one?| Stage Transition | Historical Rate | Current Quarter | Signal |
|---|---|---|---|
| Qualification to Discovery | 65% | 62% | On track |
| Discovery to Evaluation | 60% | 48% | Below trend |
| Evaluation to Business Case | 55% | 55% | On track |
| Business Case to Negotiation | 70% | 72% | On track |
| Negotiation to Closed Won | 80% | 78% | On track |
Why deal progression matters for revenue teams
Deals that progress at the historical median pace close at 2-3x the rate of deals that progress more slowly (Ebsta, 2024). The correlation between progression speed and win probability is one of the strongest in B2B sales analytics. Deals that move forward are deals where the buyer is engaged, the value proposition resonates, and the internal process is advancing.Tracking progression at the aggregate level also reveals process problems. If 40% of deals stall at the same transition point, that is not a deal problem. It is a process problem, and it affects every deal. Fixing the process can unlock a significant amount of stalled pipeline.
How to improve deal progression
- Define evidence-based stage criteria. Each stage transition should require specific buyer validation. Moving from discovery to evaluation requires the buyer to agree to evaluate your solution. Moving from evaluation to business case requires the buyer to initiate an internal ROI discussion. See pipeline management for criteria design. - Address the most common stall point first. Identify the stage transition with the lowest progression rate and investigate why. If evaluation-to-business case is your bottleneck, the fix might be better ROI tools, champion coaching, or executive engagement strategies. - Coach reps on buyer milestone selling. Reps should plan each deal around the next buyer milestone, not the next seller activity. "I will send a proposal" is a seller activity. "The buyer will present the business case to their VP on Thursday" is a buyer milestone. Multi-threading accelerates buyer milestones. - Use time-in-stage alerts. When a deal exceeds 1.5x the median time in any stage, trigger an alert for manager review. Early intervention on stalling deals is more effective than waiting for them to die.
Common mistakes with deal progression
Advancing deals based on seller activity, not buyer milestones. "I sent the proposal" is not progression. "The buyer reviewed the proposal and scheduled a follow-up discussion" is progression. When stages advance on seller activity alone, the pipeline looks healthier than it is. Not tracking regression. Some deals move backward: a deal in negotiation returns to evaluation because a new stakeholder raised concerns. Track regression separately from progression. High regression rates at specific stages reveal process or qualification gaps.Frequently Asked Questions
What drives deal progression?
Three factors drive progression: buyer engagement (stakeholder activity, meeting cadence), buyer commitment (validated milestones like budget approval, executive sponsorship), and process alignment (both sides agree on next steps and timeline).
How do you measure deal progression health?
Track three metrics: average days between stage changes, percentage of deals that advance vs. stall at each stage, and whether progression is backed by validated evidence or just rep confidence. Healthy progression is consistent, evidence-based, and aligned with historical patterns.
What is the most common deal progression stall point?
The evaluation-to-business case transition is where most B2B deals stall. Gartner (2024) reports that 44% of deals that reach evaluation never progress further. This stall occurs because building an internal business case requires champion effort that many deals lack.
Put these metrics to work
ORM builds custom revenue forecast models that turn concepts like deal progression into prescriptive action for your team.
Schedule a Demo